Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Sensitive

Pancreatic cancer

SUGCT · rs17688601

Strength of the evidence

1 / 4

Its strongest genetic-study result is p = 10−8, with 2 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 7,638 cases, 7,364 controls; replicated in 2,287 cases, 4,205 controls.

The effect Each copy of the C allele carried 1.14 times the odds of Pancreatic cancer (95% confidence interval 1.09-1.19); p = 1 × 10−8.

How common The C allele had a frequency of about 74% in the people studied.

Where it sits Chromosome 7, band 7p14.1 — in an intron of SUGCT.

How common each version is

AC
Korean KRGDB
A 2.0% · C 98.0%
Korean Korea4K
A 2.1% · C 97.9%
Korean Korea1K
A 2.1% · C 97.9%
Japanese ToMMo
A 3.2% · C 96.8%
World gnomAD
A 20.0% · C 80.0%
World 1000 Genomes
A 16.7% · C 83.3%
World TOPMed
A 18.7% · C 81.3%

By ancestry gnomAD

East Asian
A 4.4% · C 95.5%
European (non-Finnish)
A 26.4% · C 73.6%
African / African American
A 6.5% · C 93.5%
South Asian
A 34.6% · C 65.4%
Admixed American (Latino)
A 21.8% · C 78.2%
Middle Eastern
A 30.3% · C 69.7%
Finnish
A 27.4% · C 72.7%
Ashkenazi Jewish
A 26.9% · C 73.1%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

A/A No copy of the version the research linked to Pancreatic cancer. This is the starting point the study compared everyone against.
A/C One copy of the version the research linked to Pancreatic cancer. That is a smaller link than two copies.
C/C Two copies of the version the research linked to Pancreatic cancer. That is the strongest link of the three results. A link in a study is not a diagnosis.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Pancreatic cancer (rs17688601). MyGeneLog™. https://www.mygenelog.com/variants/rs17688601

← See all variants